Cargando…

CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer

BACKGROUND: Cell division cycle 6 (CDC6) is an essential regulator of DNA replication and plays important roles in the activation and maintenance of the checkpoint mechanisms in the cell cycle. CDC6 has been associated with oncogenic activities in human cancers; however, the clinical significance of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ye-Hwan, Byun, Young Joon, Kim, Won Tae, Jeong, Pildu, Yan, Chunri, Kang, Ho Won, Kim, Yong-June, Lee, Sang-Cheol, Moon, Sung-Kwon, Choi, Yung-Hyun, Yun, Seok Joong, Kim, Wun-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236078/ https://www.ncbi.nlm.nih.gov/pubmed/30450027 http://dx.doi.org/10.3346/jkms.2018.33.e303

Ejemplares similares

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
por: Kang, Ho Won, et al.
Publicado: (2020)

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer
por: Kim, Ye-Hwan, et al.
Publicado: (2016)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria
por: Kim, Won Tae, et al.
Publicado: (2016)

Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer
por: Yan, Chunri, et al.
Publicado: (2015)

GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2011)

Lower Levels of Human MOB3B Are Associated with Prostate Cancer Susceptibility and Aggressive Clinicopathological Characteristics
por: Kim, Eun-Ah, et al.
Publicado: (2015)

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer
por: Lee, Il-Seok, et al.
Publicado: (2017)

Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls
por: Kim, Won Tae, et al.
Publicado: (2016)

A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer
por: Piao, Xuan-Mei, et al.
Publicado: (2020)

Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone
por: Kang, Ho Won, et al.
Publicado: (2022)

Parathyroid hormone is associated with prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2020)

Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer
por: Byun, Young Joon, et al.
Publicado: (2021)

Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
por: Yun, Seok Joong, et al.
Publicado: (2015)

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
por: Kim, Won Tae, et al.
Publicado: (2018)

Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer
por: Byun, Young Joon, et al.
Publicado: (2022)

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer
por: Park, Jong-Lyul, et al.
Publicado: (2018)

Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer
por: Yoon, Hyung-Yoon, et al.
Publicado: (2013)

Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue
por: Yun, Seok Joong, et al.
Publicado: (2016)

Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue
por: Yun, Seok Joong, et al.
Publicado: (2016)

Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2
por: Kim, Ye-Hwan, et al.
Publicado: (2014)

A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy
por: Kim, Seon-Kyu, et al.
Publicado: (2021)

The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease
por: Kim, Young-Won, et al.
Publicado: (2015)

DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis
por: Yoon, Hyung-Yoon, et al.
Publicado: (2012)

Docetaxel-Induced Fatal Interstitial Pneumonitis in a Patient with Castration-Resistant Prostate Cancer
por: Min, Byung-Dal, et al.
Publicado: (2012)

Diagnostic Role of Prostate Resection in the Elderly Patients Who Experience Significant Co-Morbidity with a High Clinical Suspicion of Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2013)

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
por: Piao, Xuan-Mei, et al.
Publicado: (2022)

Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer
por: Yun, Seok Joong, et al.
Publicado: (2017)

Usefulness of a Combined Approach of T1-Weighted, T2-Weighted, Dynamic Contrast-Enhanced, and Diffusion-Weighted Imaging in Prostate Cancer
por: Min, Byung Dal, et al.
Publicado: (2012)

Elevated Insulin and Insulin Resistance Are Associated with the Advanced Pathological Stage of Prostate Cancer in Korean Population
por: Yun, Seok Joong, et al.
Publicado: (2012)

Prostate Size Correlates with Fasting Blood Glucose in Non-Diabetic Benign Prostatic Hyperplasia Patients with Normal Testosterone Levels
por: Kim, Won Tae, et al.
Publicado: (2011)

For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
por: Kim, Won Tae, et al.
Publicado: (2019)

Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer
por: Lee, Jong-Young, et al.
Publicado: (2018)

Identification of C16orf74 as a Marker of Progression in Primary Non-Muscle Invasive Bladder Cancer
por: Kim, Won Tae, et al.
Publicado: (2010)

Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study
por: Kang, Ho Won, et al.
Publicado: (2017)

Impact of Transobturator Tape Treatment on Overactive Bladder Symptoms, Particularly Nocturia, in Patients With Mixed Urinary Incontinence
por: Lee, Sang Keun, et al.
Publicado: (2014)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer
por: Chung, Jae-Wook, et al.
Publicado: (2021)

Effect of Renal Insufficiency on Stone Recurrence in Patients with Urolithiasis
por: Kang, Ho Won, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_12cdbjd4d7ne984mbcv049eenl